| Filed On | Filing |
|---|---|
| 05 Oct 2026 |
Form 4: Smith Nicholas Conrad, PRESIDENT AND CFO
Received 55,000 shares by exercise or conversion ($128K) |
| 01 Oct 2026 |
Form 4: Smith Nicholas Conrad, PRESIDENT AND CFO
Received 110,830 shares by exercise or conversion ($260K) · Sold 110,830 shares ($2.95M) · Received 24,056 shares by exercise or conversion ($56.5K) · 1 more |
| 29 May 2026 |
Form 4: Miller Andrew Craig, Director
Granted 26,000 Stock Option (right to buy) |
| 15 May 2026 |
Form 4: Etkin Amit, Director
Gave 400,000 shares as a gift |
| 14 May 2026 |
Form 4: York Gwill, Director
Granted 10,958 Stock Option (right to buy) |
| 14 May 2026 |
Form 4: Cox Christopher Nixon, Director
Granted 10,958 Stock Option (right to buy) |
| 14 May 2026 |
Form 4: Sanchez Ramiro, Director
Granted 10,958 Stock Option (right to buy) |
| 14 May 2026 |
Form 4: Manji Husseini, Director
Granted 10,958 Stock Option (right to buy) |
| 14 May 2026 |
Form 4: Dreyfus Andrew, Director
Granted 10,958 Stock Option (right to buy) |
| 03 Mar 2026 |
Form 4: Smith Nicholas Conrad, CHIEF FINANCIAL OFFICER & CBO
Gave up 2,806 shares to cover exercise price or tax ($55.3K) |
| 03 Mar 2026 |
Form 4: Etkin Amit, Director
Gave up 6,227 shares to cover exercise price or tax ($123K) |
| 13 Feb 2026 |
Form 4: Smith Nicholas Conrad, CHIEF FINANCIAL OFFICER & CBO
Granted 200,000 Employee Stock Option (Right to Buy) |
| 13 Feb 2026 |
Form 4: Savitz Adam, CHIEF MEDICAL OFFICER
Granted 124,000 Employee Stock Option (Right to Buy) |
| 13 Feb 2026 |
Form 4: Etkin Amit, Director
Granted 306,000 Employee Stock Option (Right to Buy) |
| 13 Feb 2026 |
Form 4: Hanley Jr. Michael Conick, CHIEF OPERATING OFFICER
Granted 131,000 Employee Stock Option (Right to Buy) |
| 06 Jan 2026 |
Form 4: York Gwill, Director
Granted 5,243 Stock Option (right to buy) ($62K) |
| 06 Jan 2026 |
Form 4: Cox Christopher Nixon, Director
Granted 7,189 Stock Option (right to buy) ($85K) |
| 06 Jan 2026 |
Form 4: Manji Husseini, Director
Granted 4,228 Employee Stock Option (right to buy) ($50K) |
| 06 Jan 2026 |
Form 4: Sanchez Ramiro, Director
Granted 3,806 Stock Option (right to buy) ($45K) |
| 14 Aug 2025 |
Form 4: Sanchez Ramiro, Director
Granted 34,502 Stock Option (right to buy) |
Loading...